• About
  • Privacy & Policy
  • Contact
Wednesday, May 25, 2022
  • Login
MYTECHMAG-A Leading Technology Magazine
DWS Top Banner
Renewable Energy Power Purchase Agreements Top Banner
Cyber Defense Top Banner
Payments Summit Europe Top Banner
Digital Transformation Conference Top Banner
LNG Top Banner
Project Finance & Project Financial Modelling Top Banner
Energy Storage Top Banner
OGAD Top Banner
Data Driven Oil & Gas 2022 Top Banner
Exhivits The Virtual Exhibition Top Banner
CCUS Top Banner
Qube Events NPF Top Banner
  • Home
  • Technology
    • Supply Chain
    • Enterprise Security
    • Cloud Technology
    • RegTech
    • HPC
    • Collaboration
    • IOT
    • Compliance
    • Artificial Intelligence
    • Field Service
    • CRM
    • Project Management
    • Fintech
    • Risk Management
    • Cyber Security
    • Enterprise Architecture
    • EAM
    • ECM
    • Block Chain
    • Data Analytics
    • Robotics
    • Disaster Recovery
    • Marketing
  • Industry
    • Retail
    • Healthcare
    • Construction
    • Pharma
    • Education
    • Textile
    • Aerospace and Defense
    • Banking
    • Smart City
    • Oil and Gas
    • Telecom
    • Travel & Hospitality
    • Agri Tech
    • Media & Entertainment
    • Logistics
    • Manufacturing
    • Legal
    • Government
    • Real Estate
    • Automotive
    • Food and Beverage
    • Biotech
    • HR
    • Insurance
    • Energy and Utilities
    • Contact Center
    • Capital Market
    • Chemical
    • Sports
  • Vendors
    • Aerospace and Defense
    • Agri Tech
    • Artificial Intelligence
    • Automotive
    • Banking
    • Capital Market
    • Cloud Technology
    • Collaboration
    • Construction
    • Contact Center
    • CRM
    • Cyber Security
    • Data Analytics
    • Disaster Recovery
    • EAM
    • ECM
    • Energy and Utilities
    • Enterprise Architecture
    • Enterprise Security
    • Fintech
    • Government
    • Healthcare
    • Insurance
    • IOT
    • Legal
    • Logistics
    • Manufacturing
    • Marketing
    • Oil and Gas
    • Pharma
    • Retail
    • Risk Management
    • Smart City
    • Supply Chain
    • Top CEOs
  • Magazines EditionsMost Clicked
  • News
  • Featured Articles
  • Top CEOs
  • Events
No Result
View All Result
  • Home
  • Technology
    • Supply Chain
    • Enterprise Security
    • Cloud Technology
    • RegTech
    • HPC
    • Collaboration
    • IOT
    • Compliance
    • Artificial Intelligence
    • Field Service
    • CRM
    • Project Management
    • Fintech
    • Risk Management
    • Cyber Security
    • Enterprise Architecture
    • EAM
    • ECM
    • Block Chain
    • Data Analytics
    • Robotics
    • Disaster Recovery
    • Marketing
  • Industry
    • Retail
    • Healthcare
    • Construction
    • Pharma
    • Education
    • Textile
    • Aerospace and Defense
    • Banking
    • Smart City
    • Oil and Gas
    • Telecom
    • Travel & Hospitality
    • Agri Tech
    • Media & Entertainment
    • Logistics
    • Manufacturing
    • Legal
    • Government
    • Real Estate
    • Automotive
    • Food and Beverage
    • Biotech
    • HR
    • Insurance
    • Energy and Utilities
    • Contact Center
    • Capital Market
    • Chemical
    • Sports
  • Vendors
    • Aerospace and Defense
    • Agri Tech
    • Artificial Intelligence
    • Automotive
    • Banking
    • Capital Market
    • Cloud Technology
    • Collaboration
    • Construction
    • Contact Center
    • CRM
    • Cyber Security
    • Data Analytics
    • Disaster Recovery
    • EAM
    • ECM
    • Energy and Utilities
    • Enterprise Architecture
    • Enterprise Security
    • Fintech
    • Government
    • Healthcare
    • Insurance
    • IOT
    • Legal
    • Logistics
    • Manufacturing
    • Marketing
    • Oil and Gas
    • Pharma
    • Retail
    • Risk Management
    • Smart City
    • Supply Chain
    • Top CEOs
  • Magazines EditionsMost Clicked
  • News
  • Featured Articles
  • Top CEOs
  • Events
MYTECHMAG-A Leading Technology Magazine
No Result
View All Result
MYTECHMAG-A Leading Technology Magazine
No Result
View All Result
Home Pharma

Gene Therapy and Biotechnology

Michael Stewart by Michael Stewart
October 29, 2018
in Pharma
Gene Therapy and Biotechnology
21
SHARES
83
VIEWS

Gene therapy guarantees to transform medicine by treating the causes of disease rather than the manifestations. Researchers are fast approaching the end of the first decade of gene therapy, and we see what type of approaches that have been taken, the outcomes achieved, lessons discovered and significant recent developments. The early results on the clinical effectiveness of gene therapies were ineffective, mainly because the possible gene-transfer vectors determined to be inadequate. Recently, however, the clinical exhibition has been demonstrated and significant progress made in selecting and improving vectors. There is now every prospect that the second decade will see gene therapy live up to its tremendous potential.

Research and advancement in modern biotechnology and gene technology incorporate a broad domain from stem cell research and the improvement of medical genetic testing to the application of genetically modified plants, animals and microorganisms (including viruses). Contemporary biotechnology can offer new solutions in some areas such as health services, the legal system, and food production. At the corresponding time, some development is met with dubiousness by researchers and the general public. The correlation between benefit and risk is an extraordinary aspect of the debate.

Since advanced biotechnology may lead to significant social changes, it is argued that people, in general, should be involved in the decision-making processes. In this way, the authorities and those who develop the technology can achieve a more holistic picture of the outcomes the technology may have for social development. The prominent question is: How do we do this? Modern biotechnology and gene technology raise many different research ethics questions that require additional scrutiny and debate.

Methods of Gene Therapy:

The critical concern in gene therapy is the dynamic delivery of the transgene (the correct exogenous gene) to the destination site and its stationary regulated explanation. The usual perfect form of gene therapy would be to replace the defective gene with a functioning transgene effectively. The practice would enable treatment for all types of mutation including official ones.

Such gene replacement would include homologous recombination connecting the transgene and the chromosomal copy. Germline therapy needs gene replacement therapy because this is the only way to be sure that the gene will be displayed in a typical fashion.

Working Together:

In somatic gene therapy, the gene extension may be accomplished rather than gene renewal, where the transgene works adjacent the mutated (defective) gene in the corresponding cell also called gene accretion. It allows reconstruction of the lack of gene function that transpires in recessive condition. But such gene addition therapy penitentiary corrects a dominant mutation where the mutant protein will still be presented and exhibit its effect.

Antisense mRNA can be employed to inhibit such gene affected by a domineering mutation. In this case, antisense mRNA or an oligonucleotide that is corresponding to the mRNA molecule originating from the defective mutant gene, can be interjected. The mRNA and the antisense mRNA will form a double-stranded hybrid which cannot be translated and, so, will be degraded. However, such antisense mRNA artifices are still not available enough for practical use.

Ethical Problems to Gene therapy:

The ethical guidelines for initiating gene therapy in its immediate form are well-established. The trial treatment will be launched only after thorough review at several levels, and it should perpetually protect the advantages of the patient.

Therefore, in somatic gene therapy, only one person is affected. So the treatment may be done with the agreement and consent of the subject. But in the case of germ line therapy, the improved DNA will be consolidated into all the cells of the individual presented from the genetically-altered genome, including his or her germ cells.

So, here, people of future generations will be feigned without their permission. Now the question is whether the next generations have the right to decide for future ages. Thus far, the interests have outweighed the generous benefits, and such examination or treatment is outlawed.

Share1Tweet5Share8
Previous Post

Automated Kiosks for Retail: Making Shopping Easier

Next Post

Technology Promise and Pitfalls in Healthcare and Medicine

Michael Stewart

Michael Stewart

Related Posts

Iptor Company Logo
Pharma Solution Providers

Addressing Specific Needs of the Pharma Industry

March 3, 2022
CobbleStone Software Logo
Pharma Solution Providers

Enhancing Contract Management

March 3, 2022
Pharma & Life Sciences Edition Feb 2022
Pharma edition

Pharma & Life Sciences Edition Feb 2022

March 2, 2022
Next Post
Dr. Chris E. Stout, Vice President, ATI Physical Therapy

Technology Promise and Pitfalls in Healthcare and Medicine

Cyber Defense Side Banner
Renewable Energy Power Purchase Agreements Side Banner
Data Driven Oil & Gas 2022 Side Banner
Project Finance & Project Financial Modelling Side Banner
DWS Side Banner
LNG Side Banner
Qube Events NPF Side Banner
OGAD Side Banner
CCUS Side Banner
Exhivits The Virtual Exhibition Side Banner
Energy Storage Side Banner
Payments Summit Europe Side Banner
Digital Transformation Conference Side Banner
Tweets by MyTechMag
OGAD Side Banner
MYTECHMAG

Transforming news into insights, not only do we serve as a source of information but as the breeding ground for innovative ideas and exchange of breathtaking strategizes that can make a difference in your technological understanding.

Follow Us

  • Home
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Sitemap
  • News
  • Subscribe
  • Contact Us
  • RSS
  • Write For Us

Recent Posts

What is the Impact of Aerospace and Defense on the US Economy?

What is the Impact of Aerospace and Defense on the US Economy?

May 25, 2022
Stephen Kosslyn

Stephen Kosslyn Net Worth, Biography, Age, Career, Salary & More 

May 24, 2022
  • About
  • Privacy & Policy
  • Contact

© Copyright © 2022 MYTECHMAG. All Right Reserved.

No Result
View All Result
  • Home
  • Technology
  • Industry
  • Vendors
  • Magazines Editions
  • News
  • Featured Articles
  • Top CEOs
  • Events

© Copyright © 2022 MYTECHMAG. All Right Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In